Highly Effective of Gemcitabine and Cisplatin (GP) as First-Line Combination Therapy in Patients with Triple-Negative Metastatic Breast Cancer: Final Report of a Phase II Trial.

被引：0
|
作者：
Wang, Z. [1 ]
Hu, X. [1 ]
Wang, B. [1 ]
Wang, L. [1 ]
Zhang, J. [1 ]
Wang, H. [1 ]
Liu, G. [1 ]
Hu, Z. [1 ]
Wu, J. [1 ]
Shao, Z. [1 ]
机构：
[1] Fudan Univ, Shanghai Med Coll, Canc Hosp, Shanghai 200433, Peoples R China
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P5-19-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-19-06
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Christopher Lobo
    Gilberto Lopes
    Odalys Baez
    Aurelio Castrellon
    Annapoorna Ferrell
    Connie Higgins
    Erin Hurley
    Judith Hurley
    Isildinha Reis
    Stephen Richman
    Pearl Seo
    Orlando Silva
    Joyce Slingerland
    Keleni Tukia
    Catherine Welsh
    Stefan Glück
    Breast Cancer Research and Treatment, 2010, 123 : 427 - 435
  • [42] Systemic corticosteroid use in patients with metastatic triple-negative breast cancer treated with first-line therapy in the United States
    Downer, M. K.
    Luhn, Patricia
    Miles, David
    Kent, Matthew
    Russell, Kenneth
    O'Shaughnessy, Joyce
    CANCER RESEARCH, 2020, 80 (04)
  • [43] Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer
    Possinger, K
    Kaufmann, M
    Coleman, R
    Stuart, NSA
    Helsing, M
    Ohnmacht, U
    Arning, M
    ANTI-CANCER DRUGS, 1999, 10 (02) : 155 - 162
  • [44] Phase II trial of weekly docetaxel/gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer
    O'Shaughnessy, Joyce A.
    Pluenneke, Robert
    Sternberg, Jack
    Khandelwal, Pankaj
    Ilegbodu, Des
    Asmar, Lina
    CLINICAL BREAST CANCER, 2006, 6 (06) : 505 - 510
  • [45] PHASE-II TRIAL OF CISPLATIN AND ETOPOSIDE AS FIRST-LINE THERAPY IN METASTATIC BREAST-CARCINOMA
    LLUCH, A
    AZAGRA, P
    CERVANTES, A
    MUNOZ, M
    ALBEROLA, V
    SANTABARBARA, P
    GARCIACONDE, J
    ONCOLOGY, 1994, 51 (04) : 352 - 355
  • [46] Final results of a phase II study of liposomal cisplatin - vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer
    Farhat, F. S.
    Temraz, S.
    Kattan, J. G.
    Ibrahim, K.
    Bitar, N.
    Haddad, N.
    Hatoum, H.
    Shamseddine, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Gemcitabine (G) plus cisplatin (C) is a highly active regimen in first-line treatment of metastatic breast cancer (MBC): Results of a multicenter phase II trial
    Fuentes, H
    Calderillo, G
    Alexander, F
    Ramirez, M
    Avila, E
    Perez, L
    Aguirre, C
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S72 - S72
  • [48] FUTURE-SUPER: A randomized, subtyping-based umbrella phase II trial for first-line treatment of metastatic triple-negative breast cancer
    Shao Zhimin
    Fan, Lei
    Ma Linxiaoxi
    Wu, Songyang
    Chen, Li
    Liu, Xiyu
    Zhang, Wenjuan
    Hu, Xin
    Jiang, Yizhou
    Wang, Zhonghua
    Li, Huajun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Allouache, D
    Gawande, SR
    Tubiana-Hulin, M
    Tubiana-Mathieu, N
    Piperno-Neumann, S
    Mefti, F
    Bozec, L
    Genot, JY
    BMC CANCER, 2005, 5 (1)
  • [50] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Djelila Allouache
    Sulochana R Gawande
    Michele Tubiana-Hulin
    Nicole Tubiana-Mathieu
    Sophie Piperno-Neumann
    Fawzia Mefti
    Laurence Bozec
    Jean-Yves Genot
    BMC Cancer, 5
12345